Drawing for INIFY

USPTO serial 79345531

INIFY

Reviewed by CopyMark Law Group

Reg. 7301400Status 700Registered
Filing date
Status date
Registration date
Feb 13, 2024
Examiner
HUDSON, TAMARA BREE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INIFY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jason H. Kasner

Jason H. Kasner Lerner David LLP20 Commerce DriveCranford, NJ 07016United States

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services, namely, research and design in the field of pathology, urology, cancer diagnostic, diseases affecting cell division, image diagnosis, biology, bacteriology, chemistry, odontology, veterinary; industrial analysis and industrial research services in the field of scientific research, pathology, urology, cancer diagnostic, diseases affecting cell division, image diagnosis, biology, bacteriology, chemistry, odontology, veterinary; laboratory testing services for scientific purposes; research laboratories, namely, laboratory research in the field of pathology, urology, cancer diagnostic, diseases affecting cell division, image diagnosis, biology, bacteriology, chemistry, odontology, veterinary; services provided by medical, scientific, chemical, biological, bacteriological, veterinary and odontology research and science laboratories; scientific, medical, chemical, biological, bacteriological, veterinary and odontology laboratory services for measuring cell division; diagnostic development services for scientific purposes, scientific development of diagnosis apparatus and computer programs, computer programs for electronic image processing, computer programs for image diagnosis; scientific research and pathology research for the preparation and production of scientific and technical reports; preparation of biological samples for testing and analysis in research laboratories for scientific research purposes, preparation of biological samples for testing and analysis in research laboratories in the field of pathology, urology, cancer diagnostic, diseases affecting cell division, image diagnosis, biology, bacteriology, chemistry, odontology, veterinary; scientific research and scientific information services in the field of pathology; design and development of pathology technology; computer-aided diagnostic testing services for scientific research purposes, computer-aided diagnostic testing services for research purposes in the field of pathology, urology, cancer diagnostic, diseases affecting cell division, image diagnosis, biology, bacteriology, chemistry, odontology, veterinary; design and development of computer equipment for use in pathology; design and development of software for use in pathology; design and development of software for machine learning, deep learning and deep neural networks, for use in pathology; design and development of computer programs for electronic image processing and computer programs for diagnostic imaging; electronic storage of health data, diagnostic test results and clinical analysis results; rental of software for medical use; leasing of computer software in pathology, electronic imaging, diagnostic imaging; information, consultancy and advisory services relating to the aforesaid servicesACTIVE—
044Services for medical, veterinary and dental diagnostic testing, analysis and reporting relating to pathology, namely, diagnosis and treatment of cancer, diagnosis and treatment of diseases in the field urology, diagnosis and treatment of diseases affecting cell division, diagnosis and treatment of bacteriology diseases, diagnosis and treatment of diseases in the odontology field, diagnosis and treatment of diseases in the veterinary field; medical diagnostic and prognostic testing and analysis services; medical, veterinary and dental services featuring the compilation and issuance of medical reports to support medical, veterinary and dental decision-making; medical analysis services relating to the treatment of patients for the identification of diseases affecting cell division; medical testing and analysis for diagnostic, prognostic or treatment purposes; medical, veterinary and dental services featuring the collection and management of medical data for the treatment of individuals; medical, veterinary and dental information and consultancy relating to the analysis of medical data for the treatment of individuals; providing medical, veterinary and dental and clinical information to patients, medical professionals, dentists, veterinarians, animal owners in the form of medical reports in the field of pathology, urology, cancer diagnostic, diseases affecting cell division, image diagnosis, biology, bacteriology, chemistry, odontology, veterinary; medical, veterinary and dental and clinical diagnostic pathology services; rental of medical, veterinary and dental diagnosis apparatus, instruments and machines for medical purposes; consultancy services in the field of pathology and diagnostic, medical, veterinary and dental care; information, consultancy and advisory services relating to the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 15, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 15, 2024FIMPFINAL DISPOSITION PROCESSED—
May 13, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 24, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 13, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 13, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 9, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 9, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 13, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 27, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 28, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 28, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2023GPNXNOTIFICATION PROCESSED BY IB—
Nov 8, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 8, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 8, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Oct 20, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 20, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 20, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 19, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 19, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 19, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 12, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 20, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 30, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 30, 2023RFRRREFUSAL PROCESSED BY MPU—
Feb 9, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 8, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2023DOCKASSIGNED TO EXAMINER—
Jul 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance